New insights into interactions between the human PTH/PTHrP receptor and agonist/antagonist binding. Academic Article uri icon


  • We prepared a polyclonal antiserum [Ab-(88-97)] against residues 8-97 of the NH2-terminal tail of the human (h) parathyroid hormone (PTH)/PTH-related protein (PTHrP) receptor. Ab-(88-97) bound specifically to the receptor, as assessed by fluorescence-activated cell sorter analysis of HEK C21 cells, which stably express approximately 400,000 hPTH/PTHrP receptors per cell. Unlike PTH, Ab-(88-97) binding did not elicit either adenosine 3',5'-cyclic monophosphate or intracellular calcium concentration signaling responses in these cells. Incubation of C21 cells for 90 min at 4 degrees C with hPTH-(1-34) plus antiserum reduced the Ab-(88-97) binding to the cells by up to 40-50% of control values in a PTH concentration-dependent fashion with a half-maximal effective concentration of approximately 5 nM. The decrease in Ab-(88-97) binding caused by hPTH-(1-34) was completely reversed by coincubation with hPTHrP-(7-34). We conclude that residues 88-97 of the hPTH/PTHrPR are involved, either directly or indirectly, in agonist but not antagonist binding to the receptor.

published proceedings

  • Am J Physiol

author list (cited authors)

  • Fukayama, S., Royo, M., Sugita, M., Imrich, A., Chorev, M., Suva, L. J., Rosenblatt, M., & Tashjian, A. H.

citation count

  • 7

complete list of authors

  • Fukayama, S||Royo, M||Sugita, M||Imrich, A||Chorev, M||Suva, LJ||Rosenblatt, M||Tashjian, AH

publication date

  • February 1998